Thiotepa

• Comparison of neurocognitive outcome in two standard regimen for treatment of low-risk medulloblastoma (COGNITO-MB) Pending
  2024-517133-40-00 Phase III 5 countries GPOH gGmbH
• A phase I/II open label study to assess safety, feasibility and efficacy of ex vivo expanded, autologous haematopoietic stem and progenitor … Pending
  2024-518972-30-00 Phase I (FiH) 1 country Fondazione Telethon Ets; San Raffaele Hospital
• Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL. Recruiting
  2025-522052-13-00 Phase II/III 9 countries Ospedale Pediatrico Bambino Gesu
• CAR-T-cell treatment for untreated high risk MANtle Cell Lymphoma Recruiting
  2022-502405-15-01 Phase II 5 countries Klinikum Der Universitat Munchen AöR
• ALL SCTped 2012 FORUM - Allogeneic Stem Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukaemia Recruiting
  2024-512657-24-00 Phase II/III 12 countries St. Anna Childrens Cancer Research Institute GmbH
• HR-NBL2: High-risk neuroblastoma study 2.0 of SIOP-Europe- Neuroblastoma/SIOPEN: Randomised, international and multicentric phase 3 study t… Recruiting
  2024-514917-36-00 Phase III 13 countries Institut Gustave Roussy
• Randomized Phase 2 study testing two conditioning regimen with a single prophylaxis of graft-versus-host disease by cyclophosphamide and met… Recruiting
  2023-509042-35-01 Phase II 1 country Centre Hospitalier Universitaire De Nantes
• TCRaß+CD19+ depleted haploidentical stem cell transplantation followed by immunotherapy in patients with relapsed/resistant high-risk neurob… Recruiting
  2024-519089-32-02 Phase II 1 country IRCCS Istituto Giannina Gaslini
• Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line tr… Recruiting
  2024-512320-11-00 Phase III 2 countries Medical Center - University Of Freiburg
• International multicenter, open-label clinical trial for the treatment of acute myeloid leukemia in children and adolescents Recruiting
  2022-500783-35-00 Phase III 6 countries GPOH gGmbH
• SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years. Recruiting
  2024-510578-25-00 Phase III 10 countries The University Of Birmingham
• The study is aimed at evaluating the feasibility of a hypomethylating treatment combined with hematopoietic stem cell transplantation in com… Recruiting
  2023-510515-19-00 Phase III 1 country Fondazione Gimema Franco Mandelli Onlus
• An international trial for children with atypical teratoid/rhabdoid tumours (ATRT) Recruiting
  2022-501456-28-00 Phase III 12 countries GPOH gGmbH
• Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international r… Recruiting
  2024-516196-32-00 Phase III 2 countries Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
• An interventional, open-label, Phase II study, to evaluate safety and efficacy of standard and high-dose chemotherapy associated with cranio… Ended
  2024-518964-11-01 Phase II 1 country Azienda Ospedaliera Universitaria Meyer IRCCS
• Optimizing MATRix, a combination of Methotrexate, Ara-C, Thiotepa and Rituximab given as an induction therapy, de-escalated in duration and … Ended
  2024-514473-21-00 Phase III 3 countries Klinikum Der Landeshauptstadt Stuttgart gKAöR
• FIBRAPLO - Haplo-identical transplantation in patients with myleofibrosis Ended
  2024-513325-23-00 Phase II 1 country Assistance Publique Hopitaux De Paris
• RB SFCE 2009 : Adjuvant treatment in extensive unilateral retinoblastoma primary enucleated Ended
  2024-514844-10-00 Phase II 1 country Institut Curie

Showing 1–18 of 18 trials